Elevated concentrations of Neu5Ac and Neu5,9Ac
Biomarker
Cardiovascular Disease
Inflammation
ROC analysis
Sialic acid
Journal
Glycoconjugate journal
ISSN: 1573-4986
Titre abrégé: Glycoconj J
Pays: United States
ID NLM: 8603310
Informations de publication
Date de publication:
22 Nov 2023
22 Nov 2023
Historique:
received:
19
05
2023
accepted:
30
10
2023
revised:
25
10
2023
medline:
22
11
2023
pubmed:
22
11
2023
entrez:
22
11
2023
Statut:
aheadofprint
Résumé
Cardiovascular disease (CVD) is a group of health conditions affecting the heart and vascular system with very high prevalence and mortality rates. The presence of CVD is characterised by high levels of inflammation which have previously been associated with increased plasma concentrations of N-acetyl neuraminic acid (Neu5Ac). While Neu5Ac has been studied in the context of CVD, Neu5,9Ac
Identifiants
pubmed: 37991561
doi: 10.1007/s10719-023-10138-3
pii: 10.1007/s10719-023-10138-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : MR/P015786/1
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Tsao, C.W., Aday, A.W., Almarzooq, Z.I., et al.: Heart Disease and Stroke Statistics—2022 update: A Report from the American Heart Association. Circulation. 145(8), E153–E639 (2022)
doi: 10.1161/CIR.0000000000001052
pubmed: 35078371
Sun, H.J., Wu, Z.Y., Nie, X.W., Bian, J.S.: Role of endothelial dysfunction in Cardiovascular Diseases: The Link between inflammation and hydrogen sulfide. Front. Pharmacol. 0, 1568 (2020)
doi: 10.3389/fphar.2019.01568
Shah, T., Casas, J.P., Cooper, J.A., et al.: Critical appraisal of CRP measurement for the prediction of coronary Heart Disease events: New data and systematic review of 31 prospective cohorts. Int. J. Epidemiol. 38, 217–231 (2008)
doi: 10.1093/ije/dyn217
pubmed: 18930961
pmcid: 2639366
Browning, L.M., Krebs, J.D., Jebb, S.A.: Discrimination ratio analysis of inflammatory markers: Implications for the study of inflammation in chronic Disease. Metabolism. 53(7), 899–903 (2004)
doi: 10.1016/j.metabol.2004.01.013
pubmed: 15254884
Cheeseman, J., Kuhnle, G., Stafford, G., Gardner, R.A., Spencer, D.I., Osborn, H.M.: Sialic acid as a potential biomarker for Cardiovascular Disease, Diabetes and cancer. Biomark. Med. 15(11), 911–928 (2021)
doi: 10.2217/bmm-2020-0776
pubmed: 34241547
Varki, A.: Sialic acids in human health and Disease, NIH Public. Access., (2008)
Visser, E.A., Moons, S.J., Timmermans, S.B.P.E., de Jong, H., Boltje, T.J., Büll, C.: Sialic acid O -acetylation: From biosynthesis to roles in health and Disease. J. Biol. Chem. 297(2), 100906 (2021)
doi: 10.1016/j.jbc.2021.100906
pubmed: 34157283
pmcid: 8319020
Kumlin, U., Olofsson, S., Dimock, K., Arnberg, N.: Sialic acid tissue distribution and Influenza virus tropism. Influenza Other Respir Viruses. 2(5), 147 (2008)
doi: 10.1111/j.1750-2659.2008.00051.x
pubmed: 19453419
pmcid: 4941897
Wasik, B.R., Barnard, K.N., Ossiboff, R.J., et al.: Distribution of O-Acetylated Sialic Acids among Target Host Tissues for Influenza Virus. mSphere 2(5) (2017)
Kelm, S., Schauer, R.: Sialic acids in Molecular and Cellular interactions. Int. Rev. Cytol. 175, 137 (1997)
doi: 10.1016/S0074-7696(08)62127-0
pubmed: 9203358
pmcid: 7133163
Pilatte, Y., Bignon, J., Lambré, C.R.: Sialic acids as important molecules in the regulation of the immune system: Pathophysiological implications of sialidases in immunity. Glycobiology. 3(3), 201–218 (1993)
doi: 10.1093/glycob/3.3.201
pubmed: 8358147
Morell, A.G., Gregoriadis, G., Scheinberg, I.H., Hickman, J., Ashwells, G.: The role of Sialic Acid in determining the survival of glycoproteins in the Circulation*. J. Biol. CHE ~ ~ ISTRY. 246(5), 1461–1467 (1971)
doi: 10.1016/S0021-9258(19)76994-4
Görög, P., Kovács, I.B.: Anti-inflammatory effect of sialic acid. Agents Actions. 8(5), 543–545 (1978)
doi: 10.1007/BF02111443
pubmed: 717187
Payazdan, M., Khatami, S., Galehdari, H., Delfan, N., Shafiei, M., Heydaran, S.: The anti-inflammatory effects of sialic acid on the human glia cells by the upregulation of IL-4 and IL-10 genes’ expressions. Gene Rep. 24, 101218 (2021)
doi: 10.1016/j.genrep.2021.101218
Visser, E.A., Moons, S.J., Timmermans, S.B.P.E., de Jong, H., Boltje, T.J., Büll, C.: Sialic acid O -acetylation: From biosynthesis to roles in health and Disease. J. Biol. Chem. 297(2) (2021)
Böhm, S., Schwab, I., Lux, A., Nimmerjahn, F.: The role of sialic acid as a modulator of the anti-inflammatory activity of IgG
Xue, Z., Zhao, H., Zhu, R., et al.: On the use of abiotic sialic acids to attenuate cell inflammation OPEN
Mjm, T.: Acute phase reaction and acute phase proteins *. J. Zhejiang Univ. SCI. 6(11), 1045–1056 (2005)
doi: 10.1631/jzus.2005.B1045
Clerc, F., Reiding, K.R., Jansen, B.C., Kammeijer, G.S., Bondt, A.: M. Wuhrer. Human plasma protein N-glycosylation. Glycoconj. J. 33(3), 309–343 (2016)
doi: 10.1007/s10719-015-9626-2
pubmed: 26555091
Hubbard, R.E., O’Mahony, M.S., Calver, B.L., Woodhouse, K.W.: Plasma esterases and inflammation in ageing and frailty. European Journal of Clinical Pharmacology 2008 64:9 64(9), 895–900 (2008)
Cheeseman, J., Kuhnle, G., Spencer, D.I.R., Osborn, H.M.I.: Assays for the identification and quantification of sialic acids: Challenges, opportunities and future perspectives. Bioorg. Med. Chem. 30, 115882 (2021)
doi: 10.1016/j.bmc.2020.115882
pubmed: 33376017
Cheeseman, J., Badia, C., Thomson, R.I., et al.: Quantitative standards of 4-O-Acetyl- and 9-O-Acetyl-N-Acetylneuraminic acid for the analysis of plasma and serum. ChemBioChem. 23(5), e202100662 (2022)
doi: 10.1002/cbic.202100662
pubmed: 34874597
pmcid: 9303589
Spichtig, V., Michaud, J., Austin, S.: Determination of sialic acids in milks and milk-based products. Anal. Biochem. 405(1), 28–40 (2010)
doi: 10.1016/j.ab.2010.06.010
pubmed: 20553868
Thomson, R.I., Gardner, R.A., Strohfeldt, K., et al.: Analysis of three epoetin alpha products by LC and LC-MS indicates differences in Glycosylation Critical Quality Attributes, including Sialic Acid Content. Anal. Chem. 89(12), 6455–6462 (2017)
doi: 10.1021/acs.analchem.7b00353
pubmed: 28509534
Ozben, T., Nacitarhan, S., Tuncer, N.: Plasma and urine sialic acid in non-insulin dependent Diabetes Mellitus. Ann. Clin. Biochem. 32(3), 303–306 (1995)
doi: 10.1177/000456329503200307
pubmed: 7632035
Alturfan, A.A., Uslu, E., Alturfan, E.E., Hatemi, G., Fresko, I., Kokoglu, E.: Increased serum sialic acid levels in primary osteoarthritis and inactive rheumatoid arthritis. Tohoku J. Exp. Med. 213(3), 241–248 (2007)
doi: 10.1620/tjem.213.241
pubmed: 17984621
Sirsikar, M., Pinnelli, V.B.K.: Elevated levels of serum sialic acid and C-reactive protein: Markers of systemic inflammation in patients with Chronic Obstructive Pulmonary Disease. Int. J. Res. Med. Sci. 4(4), 1209–1215 (2016)
doi: 10.18203/2320-6012.ijrms20160811
Cavdarli, S., Dewald, J.H., Yamakawa, N., et al.: Identification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac 2) as main O-acetylated sialic acid species of GD2 in Breast cancer cells. Glycoconj. J. 36(1), 79–90 (2019)
doi: 10.1007/s10719-018-09856-w
pubmed: 30612272
Harvey, D.J., Merry, A.H., Royle, L., Campbell, M.P., Dwek, R.A., Rudd, P.M.: Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds. Proteomics. 9(15), 3796–3801 (2009)
doi: 10.1002/pmic.200900096
pubmed: 19670245
Core Team: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria (2017). https://www.R-project.org/
Cortes, C., Vapnik, V.: Support-vector networks. Mach. Learn. 20(3), 273–297 (1995)
doi: 10.1007/BF00994018
Yndestad, A., Kristian Damås, J., Øie, E., Ueland, T., Gullestad, L., Aukrust, P.: Systemic inflammation in heart failure – The whys and wherefores. Heart Failure Reviews 2006 11:1 11(1), 83–92 (2006)
Golia, E., Limongelli, G., Natale, F., et al.: Inflammation and Cardiovascular Disease: From pathogenesis to therapeutic target. Curr. Atheroscler Rep. 16(9) (2014)
Gruys, E., Toussaint, M.J.M., Niewold, T.A., Koopmans, S.J., Review: Acute phase reaction and acute phase proteins. J. Zhejiang Univ. Sci. B. 6(11), 1045 (2005)
doi: 10.1631/jzus.2005.B1045
pubmed: 16252337
pmcid: 1390650
Tertov, V.V., Sobenin, I.A., Gabbasov, Z.A., Popov, E.G., Orekhov, A.N.: Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem. Biophys. Res. Commun. 163(1), 489–494 (1989)
doi: 10.1016/0006-291X(89)92163-3
pubmed: 2775281
Hadengue, A., Razavian, S.M., Del-Pino, M., Simon, A., Levenson, J.: Influence of Sialic Acid on Erythrocyte Aggregation in Hypercholesterolemi. Thromb. Haemost. 76(12), 0944–0949 (2018)
Gracheva, E.V., Samovilova, N.N., Golovanova, N.K., et al.: Sialyltransferase activity of human plasma and aortic intima is enhanced in Atherosclerosis. Biochim. et Biophys. Acta (BBA) - Mol. Basis Disease. 1586(1), 123–128 (2002)
doi: 10.1016/S0925-4439(01)00093-X
Luan, Y.Y., Yao, Y.M.: The clinical significance and potential role of C-Reactive protein in chronic inflammatory and neurodegenerative Diseases. Front. Immunol. 9(JUN), 1302 (2018)
doi: 10.3389/fimmu.2018.01302
pubmed: 29951057
pmcid: 6008573
Yousuf, O., Mohanty, B.D., Martin, S.S., et al.: High-sensitivity C-Reactive protein and Cardiovascular Disease: A resolute belief or an elusive link? J. Am. Coll. Cardiol. 62(5), 397–408 (2013)
doi: 10.1016/j.jacc.2013.05.016
pubmed: 23727085
Shah, T., Casas, J.P., Cooper, J.A., et al.: Critical appraisal of CRP measurement for the prediction of coronary Heart Disease events: New data and systematic review of 31 prospective cohorts. Int. J. Epidemiol. 38(1), 217–231 (2009)
doi: 10.1093/ije/dyn217
pubmed: 18930961